CHEK2 BC genomes were most similar to non-HRD, ER+ BC genomes in terms of TMB, ID ratio as well as the various mutational signatures, yet they display a worse prognosis likely originating from an increased intrinsic tumor aggressiveness. The gene discussed is CHEK2; the disease is breast cancer.